Patents by Inventor Gary A. Hite

Gary A. Hite has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170290723
    Abstract: A seating system, particularly suited for personal mobility vehicles, such as wheelchairs, includes a seat cushion having pressure relieving properties and enhanced thermal conduction properties. The seat cushion includes a thixotropic fluid contained within a flexible envelope. The thixotropic fluid includes nanoparticles that enhance the thermal conduction properties of the seat cushion to increase heat transfer from a seated user to provide a reduced temperature sensory effect.
    Type: Application
    Filed: September 2, 2016
    Publication date: October 12, 2017
    Applicant: Sunrise Medical (US) LLC
    Inventors: James Christofferson, Gary Hite
  • Patent number: 5972972
    Abstract: A class of novel pyrazoles is disclosed together with the use of such compounds for inhibiting sPLA.sub.2 mediated release of fatty acids for treatment of conditions such as septic shock.
    Type: Grant
    Filed: December 3, 1997
    Date of Patent: October 26, 1999
    Assignee: Eli Lilly and Company
    Inventors: Edward D. Mihelich, Tulio Suarez, Gary A. Hite, Peter J. Doman, Stuart E. Willetts
  • Patent number: 5283361
    Abstract: This invention relates to N-hydroxy-N-[3-[2-(4'-halophenylthio)phenyl]prop-2-enyl]ureas, formulations containing those compounds and methods of using such compounds as 5-lipoxygenase inhibiting agents.
    Type: Grant
    Filed: April 8, 1992
    Date of Patent: February 1, 1994
    Assignee: Eli Lilly and Company
    Inventors: Gary A. Hite, Edward D. Mihelich, David W. Snyder, Tulio Suarez
  • Patent number: 5130485
    Abstract: This invention relates to N-hydroxy-N-[3-(2-substituted phenyl)prop-2-enyl]ureas and thioureas, formulations containing those compounds, and methods of using such compounds as 5-lipoxygenase inhibiting agents.
    Type: Grant
    Filed: April 23, 1991
    Date of Patent: July 14, 1992
    Assignee: Eli Lilly and Company
    Inventors: Gary A. Hite, Edward D. Mihelich, David W. Snyder, Tulio Suarez
  • Patent number: 5028629
    Abstract: This invention relates to 2-(substituted)-N-hydroxy-N-alkylcinnamamides of the formula: ##STR1## where R.sup.1 is C.sub.1 -C.sub.4 alkyl;n is 0 or 1;R.sup.2 is trifuloromethyl, C.sub.1 -C.sub.10 alkyl, phen(C.sub.1 -C.sub.4)alkylene or ##STR2## where m is 0, 1 or 2 and R.sup.3 is C.sub.1 -C.sub.4 alkyl; X is C.sub.1 -C.sub.6 alkyl, phenyl, phen(C.sub.1 -C.sub.4)alkylene where the phenyl ring is unsubstituted or monosubstituted with --S(O).sub.m --R.sup.3 and m and R.sup.3 are as defined above, or ##STR3## where m is 0, 1 or 2 and R.sup.4 is C.sub.2 -C.sub.12 alkenyl, C.sub.2 -C.sub.12 alkynyl, or unsubstituted or monosubstituted C.sub.1 -C.sub.20 alkyl where the substituent is CF.sub.3, C.sub.3 -C.sub.8 cycloalkyl, or phenyl,or a pharmaceutically acceptable salt thereof; formulations containing those compounds and methods of using such compounds as 5-lipoxygenase inhibiting agents.
    Type: Grant
    Filed: March 28, 1990
    Date of Patent: July 2, 1991
    Assignee: Eli Lilly and Company
    Inventors: Gary A. Hite, Edward D. Mihelich, Tulio Suarez
  • Patent number: D985969
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: May 16, 2023
    Assignee: Sunrise Medical (US) LLC
    Inventors: Gary Hite, Vasily Tsuber